Investigators sought to determine clinical predictors to identify risk for perinatal recurrence in women with bipolar disorder.
Older adults with bipolar disorder may benefit from a detailed assessment of the use of substances.
A 25-item true and false questionnaire was used to assess knowledge of bipolar disorder.
Personal recovery improved more rapidly for participants in the anxiety in bipolar disorder intervention, but not social and personal functioning.
Does Bipolar I Disorder Effect the Course of Conduct/Antisocial Personality Disorders in Adolescents?August 13, 2018
Adolescents with bipolar I disorder whose symptoms are in remission are significantly less likely to experience conduct disorder or antisocial personality disorder.
There is no distinct cut off for the Functional Assessment Short Test between none, mind, moderate, and severe functional impairment.
These findings are in line with previous research, which suggested that abuse and neglect in childhood have different effects on the brain.
As antipsychotic medications are vital to the effective management of severe psychiatric disorders, investigators sought to examine reasons for medication nonadherence in patients with schizophrenia, bipolar disorders, and other psychotic disorders.
Schizophrenia, Major Depressive Disorder, Bipolar Disorder Linked With Abnormal Functional ConnectivityJune 22, 2018
Local functional connectivity may serve as neuroimaging marker to investigate the human brain connectome.
These data may lead to a more nuanced understanding of bipolar disorder and to a better definition of the effectiveness of interventions directed at treating both personality disorders and bipolar disorder.
Investigators summarize data regarding the management of bipolar disorder during pregnancy and in the postpartum period.
Further investigation into the family-based mechanisms of childhood-onset bipolar disorder may assist in the development of future targeted, effective therapies.
Omega-3 supplementation in children with mood disorders is associated with decreased impairment in executive functioning.
Heart rate variability and specific inflammatory biomarkers can differentiate major depressive disorder from depression in bipolar disorder.
Venlafaxine was superior to lithium in reducing symptoms of both bipolar II, depression, and anxiety.
The US Food and Drug Administration has approved Abilify MyCite, which contains an ingestible sensor that records whether or not the medication was taken.
Asenapine shown to decrease the time to recurrence of manic and depressive episodes among patients with bipolar I disorder.
Psychosis was not associated with worse clinical or functional outcomes in patients with bipolar disorder.
Mixed and psychotic features and comorbid anxiety disorder were also associated with poor treatment response.
Individuals with a first manic episode with psychotic features were randomly assigned to receive lithium or quetiapine monotherapy during the randomized controlled trial.
Overall, 54% of women with bipolar disorder reported sexual distress and 39% were not satisfied with their sexual life.
Thyroid disease may be a risk factor for manic relapse in patients with bipolar disorder.
Researchers found that mood relapse episodes were delayed with risperidone long-acting injection.
An earlier diagnosis of depression is associated with having a longer delay in conversion to bipolar disorder.
The response to lurasidone between baseline and 2 weeks indicates later treatment success in bipolar depression.
Cognitive-behavioral therapy effectively lowered the relapse rate and lessened depressive symptoms.
A 36-year-old man with type 1 diabetes presents to the emergency room with hyperglycemia and possible diabetic ketoacidosis after not taking his insulin for 3 days.
Patients with high risk for bipolar disorder are more likely to exhibit decreased cognitive performance as a function of increasing overweight status.
Clinicians should monitor thyroid function when managing patients receiving lithium for bipolar disorder.
Cognitive remediation may aid neurocognitive performance, including attention, working memory, and problem solving in bipolar disorder.